• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC OVERSTITCH¿ ENDOSCOPIC SUTURING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC OVERSTITCH¿ ENDOSCOPIC SUTURING SYSTEM Back to Search Results
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Chest Pain (1776); Fever (1858); Hemorrhage/Bleeding (1888); Implant Pain (4561)
Event Type  malfunction  
Manufacturer Narrative
Combined medwatch submitted to the fda on 30/may/2023.A review of the device labeling notes the following: the current overstitch¿ endoscopic suturing system (ess) instructions for use (ifu) addressed the known and potential event of "bleeding" as follows: the apollo endosurgery overstitch¿ endoscopic suture system (ess) is intended for endoscopic placement of suture(s) and approximation of soft tissue.Warnings: only physicians possessing sufficient skill and experience in similar or the same techniques should perform endoscopic procedures.Contact of electrosurgical components with other components may result in injury to the patient and/or operator as well as damage to the device and/or endoscope.Verify compatibility of endoscopic instruments and accessories and ensure performance is not compromised.Note: refurbished scopes may no longer confirm to original specifications.Adverse events possible complications that may result from using the endoscopic suturing system include, but may not be limited to: pharyngitis / sore throat; nausea and / or vomiting; abdominal pain and / or bloating; hemorrhage; hematoma; conversion to laparoscopic or open procedure; stricture; infection / sepsis; pharyngeal, colonic and/or esophageal perforation; esophageal, colonic and/or pharyngeal laceration; intra-abdominal (hollow or solid) visceral injury; aspiration; wound dehiscence; acute inflammatory.Additional information: the device has not been returned for analysis and attempts to gather more information from the reporter is not visible as this is a literature review, and the author does not have the information for the device.The investigator determined a device history record (dhr) review is not possible.
 
Event Description
This event was discovered during a literature review.It was report that the following adverse event from the article - fever, rectal and chest pain, bleeding and hospitalization.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVERSTITCH¿ ENDOSCOPIC SUTURING SYSTEM
Type of Device
ENDOSCOPIC SUTURING SYSTEM
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC
1120 s. captail of texas hwy
bldg 1, ste 300
austin 78746
Manufacturer (Section G)
APOLLO ENDOSURGERY COSTA RICA, SRL
coyol free zone
building b 13.3
alajuela, cs CRI
CS   CRI
Manufacturer Contact
adriana russell
1120 s. captail of texas hwy
bldg 1, ste 300
austin 78746
5122795114
MDR Report Key17019919
MDR Text Key317466907
Report Number3006722112-2023-00123
Device Sequence Number1
Product Code OCW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K081853
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 05/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/30/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-